Possible Mechanism and Current Recommendation of Thromboembolism in COVID-19
DOI:
https://doi.org/10.3889/oamjms.2020.4900Keywords:
COVID-19, venous thromboembolism, thrombosis, anticoagulationAbstract
The coronavirus disease (COVID-19) has become a global pandemic with a high mortality rate. There has been emerging evidence regarding the presence of thrombosis in patients with severe COVID-19 infection. In addition, prognosis of COVID patients, once they are complicated with DVT or fatal pulmonary emboli, will also significantly decline. Hence, understanding the pathomechanism and prompt treatment of thromboembolism is important in improving the outcome in COVID-19 patients. Prophylaxis anticoagulant was proposed for all hospitalized COVID-19 patients. The aim of this article is to review the current literature regarding pathomechanism, risk assessment, diagnosis, and management of VTE.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
World Health Organization. Coronavirus Disease (COVID-19) Pandemic; 2020. Available from: https://www.who.int/ emergencies/diseases/novel-coronavirus-2019. [Last accessed on 2020 Apr 21].
Susilo A, Rumende CM, Pitoyo CW, Santoso WD, Yulianti M, Sinto R, et al. Coronavirus disease 2019 : Review of current literatures. J Penyakit Dalam Indones. 2020;7(1):45-67. https:// doi.org/10.7454/jpdi.v7i1.415
Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. Lancet Respir Med. 2020;2600(20):1-7. https://doi. org/10.1016/s2213-2600(20)30079-5
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395(10229):1054-62. https://doi.org/10.1016/ s0140-6736(20)30566-3 PMid:32171076
Klok FA, Kruip MJ, van der Meer NJ, Arbous MS, Gommers DA, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145-7. https://doi.org/10.1016/j.thromres.2020.04.041 PMid:32291094
Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, et al. Coagulopathy and antiphospholipid antibodies in patients with covid19. N Engl J Med. 2020;382(17):e38. PMid:32268022
Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(5):844-7. https://doi.org/10.1111/jth.14768 PMid:32291954
Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020;18(6):1421-4. https://doi. org/10.1111/jth.14830 PMid:32271988
Chen J, Wang X, Zhang S, Liu B, Wu X, Wang Y, et al. Findings of acute pulmonary embolism in COVID-19 patients. Lancet Infect Dis. 2020. https://doi.org/10.2139/ssrn.3548771.
Xu J, Fan J, Wu F, Huang Q, Guo M, Lv Z, et al. The ACE2/ angiotensin-(1-7)/Mas receptor axis: Pleiotropic roles in cancer. Front Physiol. 2017;8:276. https://doi.org/10.3389/ fphys.2017.00276 PMid:28533754
Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5):1094-9. https://doi.org/10.1111/jth.14817 PMid:32220112
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020;395(10223):507-13. https://doi.org/10.1016/ s0140-6736(20)30211-7
Wenzhong L, Hualan L. COVID-19: ATTACKS the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism. ChemRxiv; 2020. Available from: https://www.chemrxiv.org/articles/COVID-19_disease_ORF8_ and_surface_glycoprotein_inhibit_heme_metabolism_by_ binding_to_porphyrin/11938173. https://doi.org/10.26434/ chemrxiv.11938173.v4
Zhu MT, Wang B, Wang Y, Yuan L, Wang HJ, Wang M, et al. Endothelial dysfunction and inflammation induced by iron oxide nanoparticle exposure: Risk factors for early atherosclerosis. Toxicol Lett. 2011;203(2):162-71. https://doi.org/10.1016/j. toxlet.2011.03.021 PMid:21439359
Read R. Flawed methods in “COVID-19: Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism. ChemRxiv; 2020. Available from: https:// www.chemrxiv.org/articles/Flawed_methods_in_COVID-19_ Attacks_the_1-beta_chain_of_hemoglobin_and_captures_the_ porphyrin_to_inhibit_human_heme_metabolism_/12120912. https://doi.org/10.26434/chemrxiv.12120912
Harper BE, Willis R, Pierangeli SS. Pathophysiological mechanisms in antiphospholipid syndrome. Int J Clin Rheumtol. 2011;6(2):157-71. PMid:23487578
Luo W, Yu H, Gou J, Li X, Sun Y, Li J, et al. Clinical pathology of critical patient with novel coronavirus pneumonia (COVID 19). Preprints. 2020;2020:1-15. Available from: https://www. preprints.org/manuscript/202002.0407/v1.
Spyropoulos AC, Lipardi C, Xu J, Peluso C, Spiro TE, De Sanctis Y, et al. Modified IMPROVE VTE risk score and elevated D-dimer identify a high venous thromboembolism risk in acutely Ill medical population for extended thromboprophylaxis. TH Open. 2020;4(1):e59-65. https://doi.org/10.1055/s-0040-1705137 PMid:32190813
Konstantinides SV, Meyer G, Bueno H, Galié N, Gibbs JS, Ageno W, et al. ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS). Eur Heart J. 2020;41(4):543-603. https://doi.org/10.1016/j. rec.2020.05.013 PMid:31504429
Casey K, Iteen A, Nicolini R, Auten J. COVID-19 pneumonia with hemoptysis: Acute segmental pulmonary emboli associated with novel coronavirus infection. Am J Emerg Med. 2020;2020:30239. https://doi.org/10.1016/j.ajem.2020.04.011 PMid:32312574
Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020;2020:25829. https://doi.org/10.1002/ajh.25829 PMid:32282949
Mazzolai L, Aboyans V, Ageno W, Agnelli G, Alatri A, Bauersachs R, et al. Diagnosis and management of acute deep vein thrombosis: A joint consensus document from the European society of cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function. Eur Heart J. 2018;39(47):4208-18. https://doi.org/10.1093/eurheartj/ehx003 PMid:28329262
Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;2020:14860. https://doi.org/10.1111/jth.14810 PMid:32302462
Schünemann HJ, Cushman M, Burnett AE, Kahn SR, Beyer- Westendorf J, Spencer FA, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv. 2018;2(22):3198-225. https://doi. org/10.1182/bloodadvances.2018022954 PMid:30482763
Yale New Haven Health System. YNHHS Initial Treatment Algorithm for Hospitalized ADULTS with COVID-19. New Haven, Connecticu: Yale New Haven Health System; 2020. Available from: https://www.medicine.yale.edu/intmed/COVID- 19TREATMENT ADULT Algorithm 04142020_382832_5_ v3.pdf. [Last accessed on 2020 Apr 17].
MGH. Massachusetts General Hospital-Hematology Issues during COVID-19; 2020. Available from: https://www.massgeneral.org/ assets/MGH/pdf/news/coronavirus/guidance-from-mass-general-hematology.pdf. [Last accessed on 2020 Apr 17].
BWH. Hematology COVID-19 Protocols; 2020. Available from: https://www.covidprotocols.org/protocols/09-hematology #thrombotic-disease. [Last accessed on 2020 Apr 17].
Shi C, Wang C, Wang H, Yang C, Cai F, Zeng F, et al. Clinical Observations of Low Molecular Weight Heparin in Relieving Inflammation in COVID-19 Patients: A Retrospective Cohort Study. medRxiv; 2020. Available from: https://www.medrxiv. org/content/10.1101/2020.03.28.20046144v1.full.pdf. [Last accessed on 2020 May 02].
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. https://doi. org/10.1016/s0140-6736(20)30183-5 PMid:31986264
American Society of Hematology. COVID-19 and VTE-Anticoagulation; 2020. Available from: https://www.hematology. org/covid-19/covid-19-and-vte-anticoagulation. [Last accessed on 2020 May 02]. https://doi.org/10.1016/j.htct.2020.05.002
Farkas J. Internet Book of Critical Care (IBCC): COVID- 19; 2020. Available from: https://www.emcrit.org/ibcc/ covid19/#disseminated_intravascular_coagulation. [Last accessed on 2020 Apr 17].
Lin L, Lu L, Cao W, Li T. Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect. 2020;9(1):727-32. https://doi.org/10.1080/22221751.2020.1746199 PMid:32196410
Witt DM, Nieuwlaat R, Clark NP, Ansell J, Holbrook A, Skov J, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: Optimal management of anticoagulation therapy. Blood Adv. 2018;2(22):3257-91. https://doi.org/10.1182/bloodadvances.2018024893 PMid:30482765
Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta. 2020;506:145-8. https://doi. org/10.1016/j.cca.2020.03.022 PMid:32178975
Wang J, Hajizadeh N, Moore EE, McIntyre RC, Moore PK, Veress LA, et al. Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series. J Thromb Haemost. 2020;2020:14828. https://doi.org/10.1111/jth.14828 PMid:32267998
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2020 Dita Aulia Rachmi, Eka Prasetya Budi Mulia, Johanes Nugroho (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
